Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06494319 · ClinicalTrials.gov registry record · NA
Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App
A NA study of Traumatic Brain Injury and PTSD, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06494319: Recruiting NA study of Traumatic Brain Injury and PTSD, sponsored by The University of Texas Health Science Center, Houston.
NCT06494319 is a NA study of Traumatic Brain Injury and PTSD that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06494319, a NA study of Traumatic Brain Injury and PTSD, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to demonstrate the feasibility and utility of SIT delivered asynchronously (self-paced) via fully virtual platform with and without the aid of a mobile health application and to determine initial change over baseline in terms of reduction in PTSD symptoms and improvement in resiliency in participants receiving the virtual SIT prototype, using Linear Mixed Models (LMMs),
Conditions Studied
Interventions
- BEHAVIORAL Stress NAVIGATOR (Mobile Health Application)
- BEHAVIORAL SIT NAVIGATOR
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-28 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What NCT06494319 shows while recruiting
NCT06494319 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Stress NAVIGATOR (Mobile Health Application) is the first listed.
NCT06494319 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06494319 about?
NCT06494319 is a clinical study titled "Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App". The purpose of this study is to demonstrate the feasibility and utility of SIT delivered asynchronously (self-paced) via fully virtual platform with and without the aid of a mobile health application and to determine initial change over baseline in terms of reduction in PTSD symptoms and improvement...
What is the current status of trial NCT06494319?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-05-28. Estimated completion is 2025-06-30.
What conditions does trial NCT06494319 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, PTSD, Trauma and Stressor Related Disorders.
What interventions are being tested in trial NCT06494319?
The interventions under investigation include: Stress NAVIGATOR (Mobile Health Application) (BEHAVIORAL), SIT NAVIGATOR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06494319?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06494319 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06494319's enrollment target sits among peer trials
20 149th of 171 higher than 21 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI